Reinsmoen, N.L.
51  results:
Search for persons X
?
1

The XIIIth Banff Conference on Allograft Pathology: The Ban..:

Bruneval, P. ; Angelini, A. ; Miller, D....
American Journal of Transplantation.  17 (2017)  1 - p. 42-53 , 2017
 
?
2

Assessment of Tocilizumab (Anti–Interleukin-6 Receptor Mono..:

Choi, J. ; Aubert, O. ; Vo, A....
American Journal of Transplantation.  17 (2017)  9 - p. 2381-2389 , 2017
 
?
3

Report From a Forum on US Heart Allocation Policy:

Kobashigawa, J.A. ; Johnson, M. ; Rogers, J....
American Journal of Transplantation.  15 (2015)  1 - p. 55-63 , 2015
 
?
4

What is the Definition of a Clinically Relevant Donor HLA-S..:

Hachem, R.R. ; Reinsmoen, N.L.
American Journal of Transplantation.  15 (2015)  2 - p. 299-300 , 2015
 
?
5

Anti-Thymocyte Gamma-Globulin May Prevent Antibody Producti..:

Rafiei, M. ; Kittleson, M. ; Patel, J....
Transplantation Proceedings.  46 (2014)  10 - p. 3570-3574 , 2014
 
?
 
?
7

Calculated PRA: Initial Results Show Benefits for Sensitize..:

Cecka, J.M. ; Kucheryavaya, A.Y. ; Reinsmoen, N.L..
American Journal of Transplantation.  11 (2011)  4 - p. 719-724 , 2011
 
?
11

Analysis of Subcutaneous (SQ) Alemtuzumab Induction Therapy..:

Vo, A.A. ; Wechsler, E.A. ; Wang, J....
American Journal of Transplantation.  8 (2008)  1 - p. 144-149 , 2008
 
?
14

The Effect of Natural Killer Cell Killer Ig-Like Receptor A..:

Keller, M. D. ; Chen, D. F. ; Condron, S. A....
Journal of Clinical Immunology.  27 (2007)  6 - p. 659-659 , 2007
 
?
15

Impact of donor KIR genotype and recipient HLA ligand incom..:

Prasad, V.K. ; Chen, D.-F. ; Reinsmoen, N.L....
Biology of Blood and Marrow Transplantation.  12 (2006)  2 - p. 15 , 2006
 
1-15